Clinical Trial Update: Additive Effects of Pravastatin and Valsartan [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the additive effects of pravastatin and valsartan in patients with hypertension and high cholesterol.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension

Drugs mentioned

• Pravastatin (pravastatin)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Hypertension, High Cholesterol | Phase 4 | Status: COMPLETED